Pliant Therapeutics Inc. (PLRX)
11.70
0.46 (4.09%)
At close: Jan 15, 2025, 11:07 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 1.58M | 9.69M | 7.57M | 41.82M | 57.05M | n/a | n/a |
| Cost of Revenue | n/a | 3.68M | 3.20M | n/a | n/a | 666.00K | n/a |
| Gross Profit | 1.58M | 6.00M | 4.37M | 41.82M | 57.05M | -666.00K | n/a |
| Operating Income | -184.15M | -127.20M | -19.99M | -41.65M | -1.23M | -30.91M | -18.35M |
| Interest Income | 24.08M | 4.67M | 272.00K | 478.00K | 816.00K | 688.00K | 16.00K |
| Pretax Income | -161.34M | -123.32M | -19.71M | -41.53M | -631.00K | -30.28M | -18.33M |
| Net Income | -161.34M | -121.50M | -17.91M | -39.74M | 185.00K | -30.28M | -20.62M |
| Selling & General & Admin | 57.93M | 39.95M | 27.56M | 17.27M | 10.93M | 6.50M | 3.82M |
| Research & Development | 127.80M | 96.94M | 77.55M | 66.19M | 47.35M | 24.41M | 14.53M |
| Other Expenses | n/a | n/a | -77.55M | -366.00K | -216.00K | -49.00K | n/a |
| Operating Expenses | 185.72M | 136.88M | 27.56M | 83.46M | 58.28M | 30.91M | 18.35M |
| Interest Expense | 1.27M | 791.00K | 272.00K | 366.00K | 216.00K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 185.72M | 136.88M | 27.56M | 83.46M | 58.28M | 30.91M | 18.35M |
| Income Tax | n/a | -1.82M | -1.81M | -1.79M | -816.00K | 639.00K | 2.29M |
| Shares Outstanding (Basic) | 58.72M | 42.02M | 35.85M | 35.55M | 35.55M | 16.51M | 803.50K |
| Shares Outstanding (Diluted) | 58.72M | 42.02M | 35.85M | 35.55M | 35.55M | 16.51M | 803.50K |
| EPS (Basic) | -2.75 | -2.89 | -0.5 | -1.12 | 0.01 | -1.83 | -25.67 |
| EPS (Diluted) | -2.75 | -2.89 | -0.5 | -1.12 | 0.01 | -1.83 | -25.67 |
| EBITDA | -158.23M | -118.85M | -95.73M | -40.34M | -118.00K | -30.25M | -18.06M |
| Depreciation & Amortization | 1.84M | 3.68M | 3.20M | 1.31M | 1.11M | 666.00K | 292.00K |